World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
44975
World Ranking
13403
National Ranking
6818

Overview

Bernard H. Bochner is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research spans the field of Medicine with a primary focus on Surgery, Molecular Biology, Oncology, Urology, and Pulmonary and Respiratory Medicine. The main topics of their work include Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Epigenetics and DNA Methylation, Urological Disorders and Treatments, Cancer Immunotherapy and Biomarkers, Esophageal Cancer Research and Treatment, and Renal Cell Carcinoma Treatment.

Bochner has contributed extensively to several publication venues. Frequent venues include The Journal of Urology, where they have 73 publications, Journal of Clinical Oncology with 29 publications, Urologic Oncology Seminars and Original Investigations with 12, European Urology with 10, and Clinical Cancer Research with 7 publications.

Their recent papers cover various aspects of oncology and urology. These include:

  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients, 2022, Cell
  • Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients, 2023, Journal of Clinical Oncology
  • Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis, 2020, European Urology Oncology
  • Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial, 2022, Journal of Clinical Oncology
  • Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma, 2023, Journal of Clinical Oncology

Bochner's frequent co-authors include Eugene J. Pietzak, Guido Dalbagni, Hikmat Al-Ahmadie, David B. Solit, and Timothy F. Donahue. These collaborations highlight their active engagement in collaborative clinical and molecular oncology research.

Best Publications

  • Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients

    John P. Stein;Gary Lieskovsky;Richard Cote;Susan Groshen

  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types.

    Robert M Samstein;Chung-Han Lee;Chung-Han Lee;Alexander N Shoushtari;Alexander N Shoushtari;Matthew D Hellmann;Matthew D Hellmann

  • Comprehensive molecular characterization of urothelial bladder carcinoma

    John N Weinstein;Rehan Akbani;Bradley McIntosh Broom;Wenyi Wang

  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

    Ahmet Zehir;Ryma Benayed;Ronak H Shah;Aijazuddin Syed

  • Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology

    Ahmad Shabsigh;Ruslan Korets;Kinjal C. Vora;Christine M. Brooks

  • Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.

    Sam S. Chang;Bernard H. Bochner;Roger Chou;Robert Dreicer

  • Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.

    Harry W. Herr;Bernard H. Bochner;Guido Dalbagni;S. Machele Donat

  • Genome Sequencing Identifies a Basis for Everolimus Sensitivity

    Gopa Iyer;Gopa Iyer;Aphrothiti J. Hanrahan;Matthew Ivan Milowsky;Matthew Ivan Milowsky;Hikmat Al-Ahmadie

  • The mechanism of action of BCG therapy for bladder cancer—a current perspective

    Gil Redelman-Sidi;Michael S. Glickman;Bernard H. Bochner

  • Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial

    Bernard H. Bochner;Guido Dalbagni;Daniel D. Sjoberg;Jonathan Silberstein;Jonathan Silberstein

  • Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma

    Eliezer M Van Allen;Kent W. Mouw;Philip Kim;Gopa Iyer

  • Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer.

    Bernard H. Bochner;Guido Dalbagni;Michael W. Kattan;Paul Fearn

  • Angiogenesis in Bladder Cancer: Relationship Between Microvessel Density and Tumor Prognosis

    Bernard H. Bochner;Richard J. Cote;Noel Weidner;Susan Groshen

  • Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System).

    Valeria Panebianco;Yoshifumi Narumi;Ersan Altun;Bernard H. Bochner

  • Thrombospondin-1 Expression in Bladder Cancer: Association With p53 Alterations, Tumor Angiogenesis, and Tumor Progression

    Gary D. Grossfeld;David A. Ginsberg;John P. Stein;Bernard H. Bochner

  • Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder.

    Atreya Dash;Matthew D. Galsky;Andrew J. Vickers;Angel M. Serio

  • Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer

    Theresa M. Koppie;Angel M. Serio;Andrew J. Vickers;Kinjal Vora

  • The effect of age and gender on bladder cancer: a critical review of the literature.

    Shahrokh F. Shariat;John P. Sfakianos;John P. Sfakianos;Michael J. Droller;Pierre I. Karakiewicz

  • Urinary diversion after radical cystectomy for bladder cancer: Options, patient selection, and outcomes

    Richard K. Lee;Hassan Abol-Enein;Walter Artibani;Bernard Bochner

  • Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens.

    Bernard H. Bochner;Harry W. Herr;Victor E. Reuter

Frequent Co-Authors

Guido Dalbagni
Guido Dalbagni Memorial Sloan Kettering Cancer Center
Dean F. Bajorin
Dean F. Bajorin Memorial Sloan Kettering Cancer Center
Jonathan E. Rosenberg
Jonathan E. Rosenberg Memorial Sloan Kettering Cancer Center
Harry W. Herr
Harry W. Herr Memorial Sloan Kettering Cancer Center
David B. Solit
David B. Solit Memorial Sloan Kettering Cancer Center
Hikmat Al-Ahmadie
Hikmat Al-Ahmadie Memorial Sloan Kettering Cancer Center
Michael F. Berger
Michael F. Berger Memorial Sloan Kettering Cancer Center
Victor E. Reuter
Victor E. Reuter Memorial Sloan Kettering Cancer Center
Andrew J. Vickers
Andrew J. Vickers Memorial Sloan Kettering Cancer Center
Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Medicine but seeking alternative or complementary career options, the field of healthcare offers a variety of online degrees and pathways. Nursing professionals, for example, can advance rapidly by enrolling in online pmhnp programs. These programs prepare nurses for specialized roles in mental health, addressing growing demand in psychiatry and behavioral care.

If you have an interest in the business and management side of healthcare, consider pursuing healthcare administration degrees. These online degrees are designed to equip students with the leadership and organizational skills necessary for hospital and clinic management.

Prospective students seeking affordability can explore the cheapest mha online programs, which offer master’s-level education in healthcare administration without a heavy financial burden. Similarly, those aiming for the highest level of nursing leadership can investigate the cheapest online dnp programs.

Exploring these online options provides increased flexibility and access, helping you find a career path in healthcare that aligns with your goals and lifestyle.

Best Scientists Citing Bernard H. Bochner

Trending Scientists